• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Friday, January 27, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

McCullough and Liu awarded $3.7M NIH grant to study sex differences in COVID-19 outcomes

Bioengineer by Bioengineer
October 15, 2021
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A $3.7 million grant to identify patients at risk for developing chronic consequences of COVID-19 infection and discover potential underlying mechanisms leading to neuropsychiatric symptoms (NPS) has been awarded to Louise McCullough, MD, PhD, and Fudong Liu, MD, MSN, by the National Institutes of Health (NIH).

COVID biorepository

Credit: (Photo by Robert Seale)

A $3.7 million grant to identify patients at risk for developing chronic consequences of COVID-19 infection and discover potential underlying mechanisms leading to neuropsychiatric symptoms (NPS) has been awarded to Louise McCullough, MD, PhD, and Fudong Liu, MD, MSN, by the National Institutes of Health (NIH).

McCullough, professor and the Roy M. and Phyllis Gough Huffington Distinguished Chair in the Department of Neurology with McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth Houston), and Liu, an associate professor in the Department of Neurology, will study whether sex-specific immune responses to SARS-CoV-2, the virus that causes COVID-19, lead to chronic neurologic symptoms in individuals. These include NPS symptoms such as depression and sleep impairment.

“This grant will allow us to understand the mechanisms that contribute to long-term consequences of COVID-19 infection, and how they differ in men and women,” said McCullough, who sees patients at UTHealth Neurosciences. “Obtaining this award, in addition to the philanthropic support from the Huffington Foundation that helped us develop this biobank, has allowed us to develop a very unique resource. This will be invaluable as we develop new strategies to address the long-term consequence of COVID infection.”

The research team includes H. Alex Choi, MD, with the Department of Neurology and Vivian L. Smith Department of Neurosurgery at McGovern Medical School; Jude Savarraj, PhD, with the neurosurgery department; and Hilda Ahnstedt, PhD, with the neurology department.

The longitudinal, prospective study will assess the impact of acute and chronic inflammation on markers of brain injury and long-term NPS for up to two years after COVID-19 infection. To accomplish this, the team will leverage a biorepository that has enrolled more than 800 hospitalized COVID-19 subjects from three different hospitals. Follow-up will occur with enrolled patients in the COVID-19 Center of Excellence clinic at UTHealth Houston.

Sex differences in outcomes from COVID-19 are already increasingly evident, McCullough said. Men have worse outcomes with acute COVID-19 infection, with higher hospitalization rates and mortality – an effect seen globally. However, according to McCullough’s preliminary data, women may be disproportionally affected by the chronic effects of infection, including higher rates of chronic symptoms.

Both clinical and experimental studies in McCullough’s and Liu’s groups have also shown that sex differences in immune responses underlie differences in acute disease course. Men have a more robust innate immune response to acute COVID-19 infection, with increased circulating neutrophils and monocytes and higher serum levels of inflammatory cytokines and markers of brain injury. Meanwhile, women have more circulating T and B cells in response to acute infection compared to men, hallmarks of an antigen-specific immune response.

“Given that male and female COVID-19 patients mount different immune responses, and also have different outcomes, it is very promising to develop sex-specific therapeutic strategies that may be more effective for these patients,” Liu said. “Our NIH-funded COVID-19 research project aims to help develop these strategies.”

To date, more than 15 million Americans have been infected with the virus that causes COVID-19. While the vast majority survive the acute illness, many are at risk for experiencing long-term, acute neurologic symptoms afterward, such as encephalitis, stroke and seizure.

Yet more and more, even survivors without acute neurologic symptoms are reporting NPS from their illness. Interestingly, the incidence and factors that influence the development of long-term NPS are unknown.

What is known is that infection triggers a systemic pro-inflammatory response termed a “cytokine storm,” or an uncontrolled release of pro-inflammatory molecules. But the consequences of uncontrolled systemic inflammation on the brain and the link to long-term NPS after COVID-19 is also unknown.

The research team believes this work is critical to solving the puzzle and enhancing the health of millions of COVID-19 survivors.

“Men and women have very different immune responses to infection, and this is one of the first studies to examine the immune response and how it changes over time in the COVID-19 disease,” McCullough said. “If we can identify early biomarkers that predict later cognitive outcomes, we may be able to intervene to prevent long-term consequences of COVID-19.”



Share12Tweet8Share2ShareShareShare2

Related Posts

Motile Sperm and Frequent Abortions in Spreading Earthmoss

Motile sperm and frequent abortions in spreading earthmoss

January 27, 2023
Pictures of natural Physostegia chlorotic mottle virus (PhCMoV)-infected plants.

A transnational collaboration leads to the characterization of an emergent plant virus

January 26, 2023

Study shows that bioprinted artificial skin can be used in cosmetics and drugs testing

January 26, 2023

First report of rare cat discovered on Mt. Everest

January 26, 2023

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    63 shares
    Share 25 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    57 shares
    Share 23 Tweet 14
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Artificial intelligence used to predict space weather

Non-invasive neurotechnology reduces symptoms of insomnia and improves autonomic nervous system function

Stability of perovskite solar cells reaches next milestone

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In